Detalhe da pesquisa
1.
Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
Brain
; 145(11): 4056-4064, 2022 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026840
2.
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.
Alzheimers Dement
; 13(3): 274-284, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341065
3.
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
Alzheimers Dement
; 13(3): 285-295, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341066
4.
Validation of soluble amyloid-ß precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases.
J Neurochem
; 137(1): 112-21, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26748905
5.
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.
Alzheimers Dement
; 12(2): 154-163, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26368321
6.
A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aß42.
Alzheimers Dement
; 11(12): 1452-1460, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26086184
7.
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.
Alzheimers Dement
; 11(12): 1461-1469, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26092348
8.
Investigating Tissue-Specific Abnormalities in Alzheimer's Disease with Multi-Shell Diffusion MRI.
J Alzheimers Dis
; 90(4): 1771-1791, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336929
9.
Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study.
J Alzheimers Dis
; 83(2): 623-639, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34334402
10.
Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm.
Neuroimage Clin
; 26: 102243, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32193172
11.
Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F]THK5351 uptake in progressive supranuclear palsy.
Neuroimage Clin
; 24: 102091, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31795034
12.
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging.
Neuroimage Clin
; 22: 101771, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30927601
13.
Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.
Neurology
; 90(11): e932-e939, 2018 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29444971
14.
A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).
J Alzheimers Dis
; 63(4): 1509-1522, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29782314
15.
Validation of the Semiquantitative Static SUVR Method for 18F-AV45 PET by Pharmacokinetic Modeling with an Arterial Input Function.
J Nucl Med
; 58(9): 1483-1489, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28336779
16.
EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.
J Alzheimers Dis
; 55(1): 53-58, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27636837
17.
Multicenter Analytical Validation of Aß40 Immunoassays.
Front Neurol
; 8: 310, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28725210
18.
No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis.
Alzheimers Res Ther
; 9(1): 49, 2017 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28709448
19.
The Cerebrospinal Fluid Aß1-42/Aß1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
J Alzheimers Dis
; 60(2): 561-576, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869470
20.
Consensus guidelines for lumbar puncture in patients with neurological diseases.
Alzheimers Dement (Amst)
; 8: 111-126, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28603768